After years of being watered down by modern over-sensitivity, science fiction may be on the verge of a raunchy, sexy ...

Unapproved peptide drugs have become a trendy new approach to building muscle, smoothing wrinkles and trying to live longer.

Ascendis Pharma A/S (Nasdaq: ASND) today announced that pivotal Week 52 results from its randomized double-blind, ...

Our progress developing ABS-201 for androgenetic alopecia is ahead of plan as we expect to initiate a phase 1/2a trial in ...